bpc 157 and thymosin beta bpc-157 beta-4 benefits Two peptides that researchers have been studying for tissue BPC-157 / Thymosin Beta-4 Nasal

Routes of Administration: After a drug is reconstituted with sterile water, the resulting solution can be given by intravenous (IV) injection into a vein, intramuscular (IM) injection into a muscle, or subcutaneous (SC) injection under the skin according to the medications requirements

View Protocol Complete dosage protocol and reconstitution guide for CJC-1295 DAC (2 mg Vial)

Aliquot and label divide into single-use portions

Others take 5-10 minutes of patient, intermittent rolling

On WADA status, AOD-9604 is explicitly prohibited under Section S0 (Non-Approved Substances) and is banned at all times, in and out of competition

Month 3: Bloodwork baseline serum B12